CDTX stock · CE stock

CDTX vs CE

Cidara Therapeutics Inc (CDTX) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.

Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.

Celanese Corporation (CE) is a chemicals company listed on US.

Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.

Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.

CDTX currently screens at market cap $6.96B. CE currently screens at market cap $5.92B.

Not investment advice. Open the CDTX and CE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons